Carl Zeiss Meditec AG
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Carl Zeiss Meditec AG generated cash of $247,319,000, which is less than the previous year. Cash used in financing activities reached the amount of $176,249,000 last year. Net change in cash is therefore $9,684,000.
Cash Flow
| 2015 | 56.74M | -35.17M | -19.29M |
|---|---|---|---|
| 2016 | 111.77M | 77.33M | -195.02M |
| 2017 | 37.73M | -55.93M | 14.49M |
| 2018 | 187.20M | -28.87M | -157.23M |
| 2019 | 219.63M | -145.84M | -58.63M |
| 2020 | 178.52M | -71.94M | -122.96M |
| 2021 | 362.66M | -75.2M | -285.88M |
| 2022 | 188.19M | -148.89M | -38.23M |
| 2023 | 250.86M | -110.98M | -135.09M |
| 2024 | 247.31M | -412.30M | 176.24M |
CZMWY Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 10.60M | 7.72M | 7.43M | 6.20M | 22.63M | 6.67M | 3.92M | 8.71M | 13.04M | 10.72M |
Operating activities | ||||||||||
Net income | 180.15M | 292.00M | 295.91M | 237.51M | 123.42M | 160.57M | 126.23M | 135.77M | 99.97M | 65.56M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 132.77M | 74.06M | 69.76M | 61.58M | 60.42M | 48.37M | 31.28M | 24.23M | 20.22M | 19.16M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 21.61M | -21.17M | -74.37M | -62.10M | 54.17M | -20.60M | -113K | -48.98M | -2.56M | -36.25M |
Inventories | 24.37M | -152.60M | -74.63M | 18K | -28.42M | -11.34M | -11.75M | -33.38M | -15.18M | -9.89M |
Accounts payable | 0 | 47.09M | 33.72M | 52.69M | -25.17M | 14.69M | 921K | 15.27M | 19.15M | 0 |
Cash generated by operating activities | 247.31M | 250.86M | 188.19M | 362.66M | 178.52M | 219.63M | 187.20M | 37.73M | 111.77M | 56.74M |
Investing activities | ||||||||||
Purchases Of Investments | -3.90M | -21.59M | -5.85M | -2.41M | -25K | -4.85M | -18.22M | -16.59M | -15.12M | -117.47M |
Investments In Property Plant And Equipment | -86.81M | -65.65M | -81.97M | -66.10M | -44.98M | -46.71M | -34.75M | -39.02M | -27.91M | -16.77M |
Acquisitions Net | -1.00B | -10.66M | -61.29M | -11.50M | -27.25M | -96.33M | 2.19M | 3.25M | -4.13M | -10.30M |
Cash generated by investing activities | -412.30M | -110.98M | -148.89M | -75.2M | -71.94M | -145.84M | -28.87M | -55.93M | 77.33M | -35.17M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 315.03M | 0 | 0 |
Payments for dividends | -98.20M | -98.38M | -80.49M | -44.72M | -58.13M | -49.19M | -49.19M | -37.56M | -30.89M | -32.52M |
Repurchases of common stock | -150.07M | 0 | 0 | 0 | 0 | 0 | 0 | -1.57M | 0 | 0 |
Repayments of term debt | 400.20M | -8K | -2.05M | -17.30M | -16.05M | -13.66M | -3.51M | -3.34M | -3.23M | -1.40M |
Cash used in financing activities | 176.24M | -135.09M | -38.23M | -285.88M | -122.96M | -58.63M | -157.23M | 14.49M | -195.02M | -19.29M |
Net Change In Cash | 9.68M | 2.87M | 290K | 1.23M | -17.43M | 15.96M | 2.75M | -4.78M | -4.33M | 2.31M |
Cash at end of period | 20.28M | 10.60M | 7.72M | 7.43M | 5.20M | 22.63M | 6.67M | 3.92M | 8.71M | 13.04M |